From Information to Innovation
The member companies of the IGES Group contribute to designing infrastructures: for healthcare, transport, housing and education. For more than 40 years we have delivered research and consulting services – analyses, expert opinions, studies, concepts and strategies – in Europe.
6,000
Projects
200
Employees
14
Companies
6
Countries
Business division
Public Infrastructures in Germany
Business division
IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist
IGES Group continues to expand its consulting services for developers and manufacturers of medical devices. To this end, the IGES Institute has acquired a majority stake in Synergus RWE. » Details
Expert opinion on the calculation of capital costs for railway infrastructure
Bundesnetzagentur sets capital costs lower than DB Netz AG. » Details
IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist
IGES Group continues to expand its consulting services for developers and manufacturers of medical devices. To this end, the IGES Institute has acquired a majority stake in Synergus RWE. » Details
EU-HTA: A topic at the world`s largest Biotech Convention
The harmonization of HTA processes for innovative therapies in Europe by joint clinical assessments on EU level was the focus of IGES at the BIO International Convention 2023 in Boston. » Details
EU-HTA ahead: Experts discuss new rules at BIO-Europe Spring
The pharmaceutical industry's perspective on the initiated EU-wide assessment of new medicines is the focus of a technical discussion with IGES experts at the BIO-Europe Spring 2023. » Details
Sick leave in the third quarter of 2022: Corona infections play a smaller role
Corona infections caused comparatively few days of employee absence in the third quarter of 2022. » Details
Companies of the IGES Group
Business Area
Public Infrastructures in Germany, Austria, Switzerland
- Health
- Transport
- Education
- Housing
Business Area
LifeScience - Access to Europe
- Medtech
- Pharmaceuticals
- Digital Health
